# OnCo record heplisav-b (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/heplisav-b/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "heplisav-b" ;
  schema:name "Heplisav-B (hepatitis B vaccine, recombinant, adjuvanted)"@en ;
  schema:alternateName "Heplisav B"@en, "Heplisav-B" ;
  schema:description "Dynavax's adjuvanted hepatitis B vaccine for adults, licensed in the United States in 2017 and in the European Union in 2021."@en ;
  schema:url <https://onco.cc/drugs/heplisav-b/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/PurpleBook/2026/purplebook-search-October-data-download.csv>, <https://www.ema.europa.eu/en/medicines/human/EPAR/heplisav-b>, <https://www.who.int/news-room/fact-sheets/detail/hepatitis-b> ;
  onco:status "approved" ;
  onco:tag "preventive-vaccine", "hepatitis-b-vaccine" ;
  onco:modality "Prophylactic vaccine (recombinant, adjuvanted)" ;
  onco:approval "US 2017: Hepatitis B vaccine (recombinant), adjuvanted, BLA 125428", "EU 2021: Active immunisation against hepatitis B in adults 18 and older (EMEA/H/C/005063)" ;
  onco:related <https://onco.cc/drugs/engerix-b/>, <https://onco.cc/drugs/recombivax-hb/>, <https://onco.cc/drugs/fendrix/>, <https://onco.cc/drugs/prehevbrio/> ;
  onco:sections <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:terms <https://onco.cc/terms/hbv-hcv/> .